This month, we are highlighting our Healthier Communities initiative to bring awareness to the work we are leading in collaboration with our customers, communities, and colleagues to help advance #healthequity globally. Listen to the latest episode of #ScienceWithATwist as our program executives Fred Lowery and Meron Mathias discuss how we leverage science, innovation, and customer relationships to build thriving health ecosystems around the world. https://lnkd.in/guQQX775
Thermo Fisher Scientific
Biotechnology Research
Waltham, MA 1,585,644 followers
The World Leader In Serving Science
About us
About Thermo Fisher Scientific Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue of approximately $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
- Website
-
https://www.thermofisher.com
External link for Thermo Fisher Scientific
- Industry
- Biotechnology Research
- Company size
- 10,001+ employees
- Headquarters
- Waltham, MA
- Type
- Public Company
- Specialties
- Analytical Instruments, Laboratory Supply Chain Programs and eCommerce, Laboratory Equipment, Lab Services, Specialty Diagnostics, Life Sciences, Pharma Services, and CDMO
Locations
-
Primary
168 Third Avenue
Waltham, MA, US
Employees at Thermo Fisher Scientific
-
Jane Li
Senior Director, Pharma CDx and CRO Partnership
-
Veronika Galvez,
Category Manager at Thermo Fisher Scientific
-
Steve Marteney
Senior Technology and Software Development Leader
-
Toshiko Banno Hadden
IT Director (RETIRED), Enterprise Technology & Operations Thermo Fisher Scientific
Updates
-
Once again, Thermo Fisher has been named to the Fortune 500 annual list of the largest companies in the U.S. Thank you to our more than 120,000 colleagues for making this possible. Their passion for our Mission to enable our customers to make the world healthier, cleaner and safer fuels our growth and success, and we look forward to what we will accomplish together as we continue to enable scientific breakthroughs and build a brighter future for all.
-
While there are about 30 FDA-approved cell and gene therapies on the market, access still remains a key barrier to helping patients who can potentially benefit. Our Jon Chesnut, senior director, cell biology, shares his perspective on how our industry can help overcome these barriers with The Medicine Maker. Read more:
-
Our president of analytical services, Leon Wyszkowski, recently shared how a recent capabilities expansion at our Middleton, Wisconsin, site will help accelerate development of life-saving therapies and support our customers who provide them to patients in need. The state’s Governor Tony Evers also attended the ribbon-cutting ceremony to commemorate the event and to highlight the positive economic impact the local community will see because of the site’s expansion. Watch the news coverage from WKOW-ABC 27 http://spr.ly/6044iZ5CQ
Ribbon cut on Thermo Fisher expansion, 350 jobs coming to Middleton
wkow.com
-
We’re excited to announce the expansion of our Basel, Switzerland, site where the introduction of innovative robotics and integrated solutions for clinical trials support will help the European pharmaceutical and #biotech industry meet critical needs in the drug development process and accelerate delivery of new therapies to the patients who need them most.
-
-
We’re excited to collaborate with the National Cancer Institute (NCI) on the myeloMATCH umbrella trial in an effort to help advance research in precision oncology. This groundbreaking program will fast-track acute myeloid leukemia patient enrollment in clinical trials informed by genomic insights provided by our next-day, sequencing technology. Accelerating this research provides hope for a future in which patients will have access to the right therapies based on their genomic profile and transform their cancer treatment journey. https://bit.ly/4f1iACO
-
We’re excited to share that we’ve completed the acquisition of Olink Proteomics. Olink provides targeted protein biomarker discovery and precision proteomics. Together we will further strengthen our commitment to accelerate discoveries and scientific breakthroughs through advanced proteomics solutions. This is an exciting step for Thermo Fisher as we continue to expand our next-generation life sciences and mass spectrometry offerings for research and precision medicine. We look forward to welcoming Olink colleagues into the organization! Learn more: https://bit.ly/4cToTX8
Thermo Fisher Scientific Completes Acquisition of Olink, Announces Commencement of Subsequent Offering Period
newsroom.thermofisher.com
-
We are honored to have been named to TIME’s inaugural list of the World’s Most Sustainable Companies of 2024. The recognition underscores our commitment to the environment and sustainable business practices which is deeply rooted in our Mission to enable our customers to make the world healthier, cleaner and safer. See our CSR report to learn more about how we are making progress toward our net-zero emissions goal: https://lnkd.in/gDekchAX
Corporate Social Responsibility
corporate.thermofisher.com
-
Earlier this month, our site in Monza, Italy celebrated the grand opening of our local Training Center & Aseptic Academy. It’s a cutting-edge space that leverages augmented and virtual reality (AR/VR) to provide colleagues working across our #Steriles manufacturing capabilities – from operations to quality – with the opportunity to train in both hands-on and simulated Good Manufacturing Practice (GMP) environments. Thermo Fisher Scientific leaders – including Executive Vice President and Chief Operating Officer Michel Lagarde, Drug Product President Simona Fugazza and Vice President and General Manager for Drug Product EU and APAC Alexandre Pasini – attended the event.
-
Affiliated pages
Similar pages
Browse jobs
Stock
TMO
NYSE
20 minutes delay
$534.35
-6.27 (-1.16%)
- Open
- 541.15
- Low
- 531.475
- High
- 542.23
Data from Refinitiv
See more info on